Supplements News and Research

RSS

GIS: Tbx3 gene improves quality of stem cells reprogrammed from differentiated cells

In the 7 Feb. 2010 issue of the journal Nature, scientists at the Genome Institute of Singapore (GIS), report that a genetic molecule, called Tbx3, which is crucial for many aspects of early developmental processes in mammals, significantly improves the quality of stem cells that have been reprogrammed from differentiated cells.

7 Feb 2010

Reliv International adds new products to its portfolio

Reliv International, Inc. introduced three new products to its Relivables line at the company's national conference here today. The products represent the first extension of the Relivables line since it was introduced last August.

6 Feb 2010

New ICD-9-CM database provides FDA-approved and off-label uses for therapeutic drugs

A recently released Drug Diagnosis Coding database from RJ Health Systems provides accurate FDA-approved and Compendia-listed off-label uses for therapeutic classes such as Oncology, Anti-Emetics, Erythropoietin Stimulating Agents and Multiple Sclerosis Agents. The

5 Feb 2010

Emerson Ecologics officially launches Emerson Quality Program

Emerson Ecologics, LLC announces the official launch of the Emerson Quality Program(SM) (EQP) on their website, www.emersonecologics.com/quality. This one-of-a-kind quality assurance program for the nutritional supplements industry will showcase the quality practices of the industry's leading manufacturers.

5 Feb 2010

NIH awards CYCORE project for cancer research $2.6M

Nearly four decades after President Richard Nixon declared a "War on Cancer," the disease still claims the lives of 560,000 Americans every year, despite an annual expenditure of $5 billion by the U.S. government on research to battle it.

4 Feb 2010

CRN issues statement on "The Dietary Supplement Safety Act of 2010"

The responsible dietary supplement industry represents the health and wellness interests of more than 150 million Americans who use dietary supplements each year. The number one priority for CRN and our members is to ensure that our consumers have access to safe, beneficial products that they can incorporate into their daily wellness regimens.

4 Feb 2010

New weight-loss supplement burns calories

A new weight-loss supplement tested by the University of Oklahoma Health and Exercise Science Department has the potential to burn as many calories as a 20-minute walk, according to Joel T. Cramer, assistant professor of exercise physiology.

3 Feb 2010

MaxMuscleMass.com: Save up to 40% off the retail prices in body building supplement retail stores

MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.

3 Feb 2010

TNS, Lee International sign non-exclusive agreement to distribute TNS’s dietary supplements

Total Nutraceutical Solutions, Inc. (TNS) announced today that the company signed a non-exclusive agreement with Lee International Group Ltd (Lee International) to distribute TNS’s human and veterinary dietary supplements in the S.E Asian markets, including Mainland China.

2 Feb 2010

Tips to prevent potential health problems in the future

A new year, a new YOU! Some of the most popular resolutions include getting healthier. The Minnesota Chiropractic Association (MCA) encourages better health through lifestyle choices.

30 Jan 2010

One-day conference focuses on effective strategies for treating autism

Nourishing Hope, an autism wellness advocacy organization in San Francisco, will be hosting the Autism: Hope in Action Conference on January 30, 2010 at the South San Francisco Conference Center from 8:00 AM to 5:30 PM. Learn more at www.AutismHopeInAction.com.

30 Jan 2010

Muscle-sparing treatments could improve patient outcomes and reduce costs

A University of Kentucky researcher is investigating respiratory weakness as a factor in the morbidity of intensive-care patients and will soon be testing new treatments that could improve long-term patient outcomes while reducing costs of care.

30 Jan 2010

Study may lead to preventative and therapeutic treatments for MS patients

Previous studies have shown multiple sclerosis (MS) patients are more often born in spring than in any other season, indicating that there is an environmental risk factor for the disease. A paper in the journal Neurology, reviewed for f1000 Medicine by Emmanuelle Waubant and Ellen Mowry, now suggests that this seasonal effect is mediated by the gene HLA-DRB1.

30 Jan 2010

Food labels can help in making heart-healthy food choices

February is American Heart Month -- and a good time to make simple changes in your diet to reduce your risk for heart disease.

30 Jan 2010

UNICEF and IZA launch “Zinc Saves Kids” campaign

UNICEF and the International Zinc Association (IZA) announced today the launch of the “Zinc Saves Kids” campaign. The initiative will raise funds to support UNICEF’s zinc supplementation programs for children in developing countries.

28 Jan 2010

Ligand Pharmaceuticals acquires Metabasis Therapeutics

Ligand Pharmaceuticals Incorporated announced that it has completed the acquisition of Metabasis Therapeutics, Inc. (NASDAQ:MBRX), following approval of the transaction by Metabasis stockholders yesterday. As a result, Ligand gains a fully funded partnership with Roche, additional pipeline assets and drug discovery technologies and resources. The transaction was first announced on October 27, 2009.

28 Jan 2010

NBTY announces record results for fiscal first quarter

NBTY, Inc. (NYSE: NTY), a leading global manufacturer and marketer of nutritional supplements, today announced record results for the fiscal first quarter ended December 31, 2009.

28 Jan 2010

Chattem reports results for the year and fiscal fourth-quarter ended November 30, 2009

Chattem, Inc., a leading marketer and manufacturer of branded consumer products, today announced results for the year and fiscal fourth quarter ended November 30, 2009.

28 Jan 2010

First-quarter fiscal 2010 results announced by Nutraceutical International

Nutraceutical International Corporation today reported results for the fiscal 2010 first quarter ended December 31, 2009. Net sales for the fiscal 2010 first quarter were $44.8 million compared to $39.6 million for the same quarter of fiscal 2009. For the first quarter of fiscal 2010, net income was $3.9 million, or $0.37 diluted earnings per share, compared to net income of $3.1 million, or $0.28 diluted earnings per share, for the same quarter of fiscal 2009.

28 Jan 2010

New Candida treatment more effective than popular remedies

Kathleen Kalaf has been to hell and back in her long fight with systemic Candida. Today, thanks to a new Candida treatment that is more effective than even the most popular Candida remedies, Kalaf is finally free of the yeast overgrowth that stole eight years of her life -- and she wants other Candida sufferers to know about Candida Force (http://www.candidaforce.com).

28 Jan 2010